Google obtains atrial fibrillation clearance for its Fitbit devices

Officially, to date, smartwatches in the current market cannot officially diagnose atrial fibrillation in a user. However, many advances have taken place in recent months, including the establishment of irregular heartbeat patterns.

Thus, the Apple Watch for example, can send a notification to the wearer of the watch to ask him to consult a specialist. Today, Google obtained the same certification as Apple from the FDA for the detection of atrial fibrillation in Fitbit devices.


Fitbit devices will be able to detect irregular heartbeats

For a device to claim to help detect irregular heartbeats, and therefore potentially help detect atrial fibrillation, it must pass through the Federal Drug Administration (FDA). In 2018, Apple notably obtained this agreement for its Apple Watch, thus allowing for the great stories that we have been telling you for years on this blog.

Today, Google has officially joined Apple in enabling this feat in its Fitbit devices.

The Food and Drug Administration has given Fitbit the green light to monitor users’ heart rates in the background. A new photoplethysmography (PPG) algorithm can passively check a user’s heart rate when they are still or asleep.

If the technology detects signs of atrial fibrillation (AFib), a type of irregular heartbeat, it alerts the user. Google, Fitbit’s parent company, submitted the algorithm to the FDA for review last month [et] will soon be rolling out the background heart rate monitoring and irregular heartbeat notification features in the US. They will be available on “a range of heart rate compatible devices”.


Leave a Comment